MedTrace Logo

Human Heterologous Liver Cells for Infusion in Children With Urea Cycle Disorders

NCT01195753 · Status: TERMINATED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 10

Last updated 2016-02-08

No results posted yet for this study

Summary

Treatment with liver cell infusion for children with urea cycle disorders (UCD).

Conditions

  • Urea Cycle Disorders

Interventions

BIOLOGICAL

HHLivC

multiple infusion of liver cells

Sponsors & Collaborators

  • Cytonet GmbH & Co. KG

    lead INDUSTRY

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
1 Day
Max Age
5 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-12-31
Primary Completion
2015-12-31
Completion
2015-12-31

Countries

  • United States
  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01195753 on ClinicalTrials.gov